VAR - Varian Acquires CyberHeart For Cardiac Radioablation Tech
Quick Take
Varian (VAR) announced it has acquired CyberHeart for an undisclosed amount.
CyberHeart has intellectual property that covers cardiac radioablation - the use of radiation to scar or destroy tissue in the heart that is facilitating faulty electrical signals, causing an abnormal heart rhythm.
With the deal, VAR is adding promising radiation-based technologies for correcting chronic cardiac arrhythmia conditions.
Target Company
Mountain View, California-based CyberHeart was founded in 2006 and is the first company to develop a non-invasive, robotic cardiac ablation therapy for the treatment of heart arrhythmias with radiation that is